Your browser doesn't support javascript.
loading
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.
Uppaluri, Ravindra; Campbell, Katie M; Egloff, Ann Marie; Zolkind, Paul; Skidmore, Zachary L; Nussenbaum, Brian; Paniello, Randal C; Rich, Jason T; Jackson, Ryan; Pipkorn, Patrik; Michel, Loren S; Ley, Jessica; Oppelt, Peter; Dunn, Gavin P; Barnell, Erica K; Spies, Nicholas C; Lin, Tianxiang; Li, Tiantian; Mulder, David T; Hanna, Youstina; Cirlan, Iulia; Pugh, Trevor J; Mudianto, Tenny; Riley, Rachel; Zhou, Liye; Jo, Vickie Y; Stachler, Matthew D; Hanna, Glenn J; Kass, Jason; Haddad, Robert; Schoenfeld, Jonathan D; Gjini, Evisa; Lako, Ana; Thorstad, Wade; Gay, Hiram A; Daly, Mackenzie; Rodig, Scott J; Hagemann, Ian S; Kallogjeri, Dorina; Piccirillo, Jay F; Chernock, Rebecca D; Griffith, Malachi; Griffith, Obi L; Adkins, Douglas R.
Afiliación
  • Uppaluri R; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts. Ravindra_Uppaluri@DFCI.Harvard.edu.
  • Campbell KM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Egloff AM; Department of Genetics, Washington University School of Medicine, St. Louis, Missouri.
  • Zolkind P; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri.
  • Skidmore ZL; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Nussenbaum B; Department of Otolaryngology, Washington University School of Medicine, St. Louis, Missouri.
  • Paniello RC; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri.
  • Rich JT; Department of Otolaryngology, Washington University School of Medicine, St. Louis, Missouri.
  • Jackson R; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.
  • Pipkorn P; Department of Otolaryngology, Washington University School of Medicine, St. Louis, Missouri.
  • Michel LS; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.
  • Ley J; Department of Otolaryngology, Washington University School of Medicine, St. Louis, Missouri.
  • Oppelt P; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.
  • Dunn GP; Department of Otolaryngology, Washington University School of Medicine, St. Louis, Missouri.
  • Barnell EK; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.
  • Spies NC; Department of Otolaryngology, Washington University School of Medicine, St. Louis, Missouri.
  • Lin T; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.
  • Li T; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.
  • Mulder DT; Department of Medicine/Medical Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Hanna Y; Department of Medicine/Medical Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Cirlan I; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.
  • Pugh TJ; Department of Medicine/Medical Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Mudianto T; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.
  • Riley R; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri.
  • Zhou L; Department of Genetics, Washington University School of Medicine, St. Louis, Missouri.
  • Jo VY; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri.
  • Stachler MD; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri.
  • Hanna GJ; Department of Otolaryngology, Washington University School of Medicine, St. Louis, Missouri.
  • Kass J; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Haddad R; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Schoenfeld JD; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Gjini E; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Lako A; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Thorstad W; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Gay HA; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Daly M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Rodig SJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Hagemann IS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Kallogjeri D; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Piccirillo JF; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Chernock RD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Griffith M; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Griffith OL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Adkins DR; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
Clin Cancer Res ; 26(19): 5140-5152, 2020 10 01.
Article en En | MEDLINE | ID: mdl-32665297

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón gamma / Anticuerpos Monoclonales Humanizados / Antígeno B7-H1 / Carcinoma de Células Escamosas de Cabeza y Cuello / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón gamma / Anticuerpos Monoclonales Humanizados / Antígeno B7-H1 / Carcinoma de Células Escamosas de Cabeza y Cuello / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos